Mark Genovese

Mark Genovese

Corporate Officer/Principal chez ELI LILLY AND COMPANY
Health Technology
Consumer Services

Profil

Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.

Postes actifs de Mark Genovese

SociétésPosteDébut
ELI LILLY AND COMPANY Corporate Officer/Principal 16/10/2023

Anciens postes connus de Mark Genovese

SociétésPosteFin
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/09/2023
KYVERNA THERAPEUTICS, INC. Directeur/Membre du Conseil -
Corporate Officer/Principal -
Voir l'expérience en détail de Mark Genovese

Formation de Mark Genovese

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

21

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Genovese